Cardiac Procedure Complication
Conditions
Keywords
tissue oxygenation
Brief summary
Venoarterial CO2 difference(delta PCO2), lactate, central venous oxygen saturation(ScVO2) will be recorded in several steps in coronary artery bypass graft and valvular cardiac operations. The patients will be divided into two groups as Transfused, and Non-Transfused Groups observationally. The trend of delta CO2, lactate, ScVO2, postoperative creatinine values, postoperative complications and 28 days mortality will be compared.
Detailed description
Preoperative creatinine values, demographic data, comorbidities will be recorded in ASA I-II elective coronary artery and valvular cardiac surgery patients. Intraoperative delta PCO2, lactate, ScVO2 will be recorded in several steps. The patients will be divided into two groups as Transfused, and Non-Transfused Groups observationally. The trend of delta CO2, lactate, ScVO2, postoperative creatinine values, postoperative complications and 28 days mortality will be compared.
Interventions
The transfusion of erythrocyte suspension
Sponsors
Study design
Eligibility
Inclusion criteria
* Elective cardiac surgery, stable cardiac function
Exclusion criteria
* Clinical signs of heart failure, symptomatic cerebral or peripheral failure, uncontrolled diabetes mellitus
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Complication | 5 days | The postoperative neurologic, renal, hepatic, respiratory complications |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | 28 days | mortality |
Countries
Turkey (Türkiye)